I am hanging in there too, but concerned about the price weakness these last couple of days. What is the primary reason, do you think? Is it predicted Fusilev sales drop off? SPPI is definitely not a one-trick pony, and my investment thesis is that the market will eventually recognize this.
price weakness for a long time has been due to the manipulation of pps by the huge short interest. I just can't imagine a scenario where it can continue. The company has been forging ahead with acquisitions, developing new drugs, and hiring big names to help increase existing drug sales. Nothing points to a slow down in Fusilev sales, in fact it should continue to grow. Hoping the shorts start unraveling soon.